halothane has been researched along with Diathesis in 147 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The most commonly used laboratory test for predicting malignant hyperthermia susceptibility is the caffeine halothane contracture test." | 9.07 | Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry. ( Bunn, JS; Diaz, M; Landis, JR; Larach, MG, 1992) |
| " We evaluated whether toxic concentrations of cocaine altered the in vitro muscle response to halothane during contracture tests for MH." | 7.69 | Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia. ( Brum, JM; DeBoer, GE; Mitsumoto, H; Sato, N, 1995) |
| "The in vitro halothane and caffeine contracture tests have been performed on muscle tissue from six survivors of the neuroleptic malignant syndrome." | 7.67 | Neuroleptic malignant syndrome and malignant hyperthermia. In vitro comparison with halothane and caffeine contracture tests. ( Adnet, P; Guevart, E; Krivosic-Horber, R; Lestavel, P; Theunynck, D, 1987) |
| " The literature is briefly reviewed and an account of the present status of malignant hyperthermia (porcine stress syndrome) in Ontario boars using the halothane or halothane/succinylcholine screening tests is presented." | 7.66 | Halothane and halothane/succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars. ( Basrur, PK; McDonell, WN; Seeler, DC, 1983) |
| "The most commonly used laboratory test for predicting malignant hyperthermia susceptibility is the caffeine halothane contracture test." | 5.07 | Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry. ( Bunn, JS; Diaz, M; Landis, JR; Larach, MG, 1992) |
| " However, experts worldwide agree that the only reference test to this day remains the in vitro halothane caffeine contracture tests." | 4.77 | [Screening tests for malignant hyperthermia susceptibility]. ( Adnet, P; Krivosic-Horber, R, 1989) |
| " Diagnosis is based on in vitro muscle contracture in response to halothane and/or caffeine exposure." | 3.70 | [Malignant hyperthermia susceptibility in 3 patients with malignant neuroleptic syndrome]. ( Bahia, VS; Marchiori, PE; Oliveira, RA; Scaff, M; Silva, HC; Tsanaclis, AM, 2000) |
| " We evaluated whether toxic concentrations of cocaine altered the in vitro muscle response to halothane during contracture tests for MH." | 3.69 | Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia. ( Brum, JM; DeBoer, GE; Mitsumoto, H; Sato, N, 1995) |
| " The halothane/caffeine contracture test was performed on the biopsied muscle." | 3.69 | Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy. ( Britt, BA; Carr, AS; Cunliffe, M; Lerman, J; McLeod, ME, 1995) |
| "The early effects of 5 or 10 min global cerebral ischemia, sham operation and halothane anesthesia were evaluated in Mongolian gerbils by means of electroencephalography (EEG), neurological examination and passive avoidance training." | 3.69 | Response variability to ischemic injury in the Mongolian gerbil: an electroencephalographic and behavioral study. ( Adami, M; Ambrosini, MV; Bruschelli, G; de Rino, F; Gambelunghe, C; Mariucci, G, 1996) |
| "The in vitro contracture test determines the sensitivity of freshly obtained skeletal muscle specimens to caffeine or halothane applied to a bathing solution." | 3.68 | In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update. ( Gallagher, WJ; Iaizzo, PA; Wedel, DJ, 1991) |
| " In vitro, human MHS muscle samples were exposed to propofol and changes in (a) baseline tension and (b) contracture tension on exposure to halothane and caffeine were measured." | 3.68 | Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients. ( Couchman, KG; McKenzie, AJ; Pollock, N, 1992) |
| "The in vitro halothane and caffeine contracture tests have been performed on muscle tissue from six survivors of the neuroleptic malignant syndrome." | 3.67 | Neuroleptic malignant syndrome and malignant hyperthermia. In vitro comparison with halothane and caffeine contracture tests. ( Adnet, P; Guevart, E; Krivosic-Horber, R; Lestavel, P; Theunynck, D, 1987) |
| " Halothane-caffeine contracture tests, interpreted in accordance with the criteria of the European Group on Malignant Hyperthermia, yielded the following results: 13 positive (MHS), 10 negative (MHN), 4 equivocal (MHE)." | 3.67 | [Tests of contracture and sensitivity to malignant hyperthermia in 27 patients]. ( Adamantidis, M; Adnet, P; Guévart, E; Krivosic, I; Krivosic-Horber, R; Theunynck, D, 1988) |
| " The in vitro halothane-caffeine contracture tests are the most reliable method of identifying individuals susceptible to MH." | 3.67 | The association between the neuroleptic malignant syndrome and malignant hyperthermia. ( Adamantidis, MM; Adnet, PJ; Adnet-Bonte, CA; Dupuis, BA; Haudecoeur, G; Krivosic-Horber, RM; Saulnier, F, 1989) |
| " The literature is briefly reviewed and an account of the present status of malignant hyperthermia (porcine stress syndrome) in Ontario boars using the halothane or halothane/succinylcholine screening tests is presented." | 3.66 | Halothane and halothane/succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars. ( Basrur, PK; McDonell, WN; Seeler, DC, 1983) |
| "Masseter spasm is often associated with severe rhabdomyolysis in patients with muscle dystrophy, especially Duchenne's dystrophy." | 2.38 | [Clinical features of malignant hyperthermia crisis]. ( Cornet, C; Laxenaire, MC; Moeller, R, 1989) |
| "Patients with malignant hyperthermia susceptibility were classified into subgroups HH and HS (positive to halothane only and positive to both caffeine and halothane)." | 1.91 | Distinct pathophysiological characteristics in developing muscle from patients susceptible to malignant hyperthermia. ( Figueroa, L; Ibarra-Moreno, CA; Kraeva, N; Manno, C; Riazi, S; Rios, E; Tammineni, ER, 2023) |
| "The variable clinical presentation of malignant hyperthermia (MH), a disorder of calcium signalling, hinders its diagnosis and management." | 1.51 | Abnormal calcium signalling and the caffeine-halothane contracture test. ( Figueroa, L; Kraeva, N; Manno, C; Riazi, S; Ríos, E; Toro, S, 2019) |
| "Sevoflurane is a known triggering agent of malignant hyperthermia (MH)." | 1.39 | Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility. ( Heiderich, S; Johannsen, S; Klingler, W; Roewer, N; Schneiderbanger, D; Schuster, F, 2013) |
| "To diagnose malignant hyperthermia (MH) susceptibility, muscle bundles are exposed to halothane and caffeine." | 1.37 | Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study. ( Anetseder, M; Hartung, E; Metterlein, T; Roewer, N; Schuster, F, 2011) |
| "In vitro contracture testing to diagnose malignant hyperthermia (MH) susceptibility requires a muscle biopsy, which may be associated with severe side effects for the patient." | 1.35 | An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study. ( Anetseder, M; Kranke, P; Metterlein, T; Muellenbach, RM; Negele, S; Roewer, N; Schuster, F; Schwemmer, U, 2008) |
| " MH susceptibility leads to a leftward shift of the dose-response curve for IM lactate after local injection of halothane and caffeine." | 1.33 | The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs. ( Anetseder, M; Hager, M; Müller, R; Roewer, N; Schöll, H; Schuster, F, 2006) |
| "The effect was most pronounced in seizure-prone animals, and subsequent to anaesthetic-induced behavioural immobility, these animals also showed a regional resistance to the depression of spontaneous slow potential shift oscillations." | 1.30 | Large slow potential shifts occur during halothane anaesthesia in gerbils. ( Laming, PR; Roughan, JV, 1998) |
| "The phenotype of susceptibility to malignant hyperthermia (MHS); can only be detected reliably by the in vitro caffeine-halothane contracture test (CHCT)." | 1.30 | [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients]. ( Adnet, PJ; Ben-Abraham, R; Haudcoeur, G; Krivosic-Horber, RM; Perel, A, 1997) |
| " MHEh muscles revealed a dose-response curve similar to that found in MHN specimens." | 1.30 | Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol. ( Bittner, RE; Fricker, R; Gilly, H; Kress, HG; Musat, I; Steinbereithner, K, 1997) |
| "The association between malignant hyperthermia (MH) and neuromuscular disorders is controversial." | 1.30 | Dystrophin deficient mdx muscle is not prone to MH susceptibility: an in vitro study. ( Bittner, RE; Gilly, H; Mader, N, 1997) |
| "To investigate a possible link of malignant hyperthermia to capture myopathy, between June 1990 and July 1993 we anesthetized four black-tailed deer (Odocoileus hemionus columbianus) and challenged them with halothane and succinylcholine." | 1.29 | Evaluation for malignant hyperthermia susceptibility in black-tailed deer. ( Antognini, JF; Eisele, PH; Gronert, GA, 1996) |
| "Isoflurane has a lesser ability than halothane to induce contracture in malignant hyperthermia (MH) muscle in vitro." | 1.28 | Effect of Bay K 8644 on the magnitude of isoflurane and halothane contracture of skeletal muscle from patients susceptible to malignant hyperthermia. ( Adamantidis, MM; Adnet, PJ; Haudecoeur, G; Imbenotte, M; Krivosic-Horber, RM; Reyford, H, 1992) |
| "Pre-treatment with ryanodine did not change the calcium signal brought about by halothane or ionomycin." | 1.28 | [Effects of halothane, caffeine and ryanodine on the intracellular calcium store in blood mononuclear cells]. ( Endo, M; Iino, M; Kawana, Y; Oyamada, H, 1992) |
| "The mechanisms causing the malignant hyperthermia (MH) syndrome are related to a malfunction of intracellular Ca2+ homeostasis and can be prevented or reversed by dantrolene." | 1.28 | EU 4093 decreases intracellular [Ca2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine. ( Allen, PD; López, JR; Ryan, JF; Sánchez, V; Sreter, FA, 1992) |
| "In vitro muscle contracture tests for malignant hyperthermia screening are routinely performed using standardized protocols." | 1.28 | Effect of halothane equilibration kinetics on in vitro muscle contractures for malignant hyperthermia screening. ( Censier, K; Drewe, J; Funk, B; Urwyler, A, 1992) |
| "Halothane was dosed by chromatography in the three compartments of a bath for isolated organs with a muscular fiber during steady concentrations were given and after wash out." | 1.28 | [Malignant hyperthermia: halothane kinetics in a study model of muscular contraction. Head space determination and comparison with a mathematical model]. ( Guevart, E; Haguenoer, JM; Imbenotte, M; Theunynck, D, 1991) |
| " In six MH(-) patients with previous masseter muscle rigidity, no adverse reactions occurred in response to volatile anesthetic agents." | 1.28 | Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility. ( Allen, GC; Fletcher, JE; Rosenberg, H, 1990) |
| " In contrast, propranolol shifted the caffeine dose-response curve to the right and significantly increased the caffeine threshold in the MHS group." | 1.28 | Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle. ( Ording, H, 1989) |
| "in an attempt to induce malignant hyperthermia." | 1.27 | Failure to induce malignant hyperthermia in myotonic goats. ( Gronert, GA; Lambert, EH; Newberg, LA, 1983) |
| "Malignant hyperthermia is a potentially lethal syndrome that can be triggered by inhaled anesthetics." | 1.27 | Preparation of anesthesia machines for patients susceptible to malignant hyperthermia. ( Beebe, JJ; Sessler, DI, 1988) |
| "Malignant hyperthermia is a seemingly rare genetic myopathy." | 1.27 | Malignant hyperthermia in plastic surgery. ( Abdul-Rasool, IH; Dubrow, TJ; Lesavoy, MA; Wackym, PA, 1988) |
| "A European Malignant Hyperpyrexia Group has been formed to facilitate exchange of information between centres performing in vitro muscle testing for malignant hyperpyrexia susceptibility." | 1.27 | A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group. ( , 1984) |
| "The caffeine test was positive in 68% of MHS patients, 0." | 1.27 | Investigation of malignant hyperthermia in Denmark and Sweden. ( Fletcher, R; Ording, H; Ranklev, E, 1984) |
| "The relationship between neuroleptic malignant syndrome (NMS) and malignant hyperthermia (MH) was investigated using the in vitro skeletal muscle contracture test to screen for MH-susceptibility in NMS patients." | 1.27 | Malignant hyperthermia susceptibility in neuroleptic malignant syndrome. ( Caroff, SN; Fletcher, JE; Heiman-Patterson, TD; Mann, SC; Rosenberg, H, 1987) |
| "In vitro tests for the diagnosis of malignant hyperthermia susceptibility were performed in 105 patients and 20 normal controls according to the protocol of the European MH Group." | 1.27 | In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests. ( Ording, H; Skovgaard, LT, 1987) |
| "The familial nature of anaesthetic malignant hyperthermia must lead to the search for susceptibility in other members of the family of a sensitive subject." | 1.27 | [Examination of the family of a patient susceptible to anesthetic malignant hyperthermia]. ( Adnet, P; Guévart, E; Krivosic, I; Krivosic-Horber, R; Theunynck, D, 1986) |
| "The father was found to be malignant hyperpyrexia-susceptible." | 1.27 | Malignant hyperpyrexia and sudden death. ( Fletcher, R; Krantz, P; Ranklev, E, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 50 (34.01) | 18.7374 |
| 1990's | 78 (53.06) | 18.2507 |
| 2000's | 12 (8.16) | 29.6817 |
| 2010's | 5 (3.40) | 24.3611 |
| 2020's | 2 (1.36) | 2.80 |
| Authors | Studies |
|---|---|
| Carlson, KJ | 1 |
| Sun, SA | 1 |
| Swan, C | 1 |
| Koenig, M | 1 |
| Derkay, CS | 1 |
| Figueroa, L | 2 |
| Kraeva, N | 3 |
| Manno, C | 2 |
| Ibarra-Moreno, CA | 1 |
| Tammineni, ER | 1 |
| Riazi, S | 3 |
| Rios, E | 2 |
| Thompson, SJ | 1 |
| Noseworthy, MD | 1 |
| Rayner, TE | 1 |
| Schneiderman, JE | 1 |
| Cifra, B | 1 |
| Wells, GD | 1 |
| Toro, S | 1 |
| Johannsen, S | 1 |
| Klingler, W | 2 |
| Schneiderbanger, D | 1 |
| Heiderich, S | 1 |
| Roewer, N | 10 |
| Schuster, F | 5 |
| Sagui, E | 1 |
| Montigon, C | 1 |
| Abriat, A | 1 |
| Jouvion, A | 1 |
| Duron-Martinaud, S | 1 |
| Canini, F | 2 |
| Zagnoli, F | 1 |
| Bendahan, D | 2 |
| Figarella-Branger, D | 1 |
| Brégigeon, M | 1 |
| Brosset, C | 1 |
| Metterlein, T | 3 |
| Negele, S | 1 |
| Kranke, P | 2 |
| Muellenbach, RM | 1 |
| Schwemmer, U | 1 |
| Anetseder, M | 5 |
| Hartung, E | 3 |
| Snoeck, MM | 1 |
| Oosterhof, A | 1 |
| Tangerman, A | 1 |
| Veerkamp, JH | 2 |
| van Engelen, BG | 1 |
| Gielen, MJ | 1 |
| Islander, G | 1 |
| Ording, H | 10 |
| Bendixen, D | 2 |
| Ranklev Twetman, E | 1 |
| Allen, PD | 3 |
| López, JR | 3 |
| Sei, Y | 1 |
| Brandom, BW | 1 |
| Bina, S | 2 |
| Hosoi, E | 1 |
| Gallagher, KL | 1 |
| Wyre, HW | 1 |
| Pudimat, PA | 1 |
| Holman, SJ | 1 |
| Venzon, DJ | 1 |
| Daly, JW | 1 |
| Muldoon, S | 2 |
| Wappler, F | 5 |
| Baur, CP | 1 |
| Censier, K | 3 |
| Doetsch, S | 1 |
| Felleiter, P | 1 |
| Fiege, M | 2 |
| Fricker, R | 2 |
| Halsall, PJ | 6 |
| Heffron, JJ | 1 |
| Heytens, L | 2 |
| Hopkins, PM | 5 |
| Lehmann-Horn, F | 5 |
| Nivoche, Y | 1 |
| Tegazzin, V | 1 |
| Tzanova, I | 1 |
| Urwyler, A | 4 |
| Weisshorn, R | 1 |
| Schulte am Esch, J | 5 |
| Litman, RS | 1 |
| Rosenberg, H | 15 |
| Schöll, H | 1 |
| Hager, M | 1 |
| Müller, R | 1 |
| Bünger, R | 1 |
| Gardill, A | 1 |
| de Roose, P | 1 |
| Pauwels, H | 1 |
| Lampo, P | 1 |
| Oyaert, W | 1 |
| van den Hende, C | 1 |
| Ranklev, E | 4 |
| Fletcher, R | 4 |
| Seeler, DC | 1 |
| McDonell, WN | 2 |
| Basrur, PK | 2 |
| Gerrard, JM | 1 |
| Duncan, PG | 1 |
| Koshyk, SA | 1 |
| Glover, SM | 1 |
| McCrea, JM | 1 |
| Newberg, LA | 1 |
| Lambert, EH | 1 |
| Gronert, GA | 4 |
| Reed, S | 1 |
| Nelson, TE | 3 |
| Flewellen, EH | 1 |
| Gloyna, DF | 1 |
| Dantzer, R | 1 |
| Hatey, F | 1 |
| Tonner, PH | 1 |
| Scholz, J | 4 |
| Richter, A | 1 |
| Löscher, W | 1 |
| Steinfath, M | 3 |
| Wlaz, P | 1 |
| Hadji, B | 1 |
| Singh, S | 2 |
| Becker, K | 1 |
| Lenzen, C | 1 |
| Köchling, A | 2 |
| Sato, N | 1 |
| Brum, JM | 1 |
| Mitsumoto, H | 1 |
| DeBoer, GE | 1 |
| Bello, N | 1 |
| Adnet, P | 6 |
| Saulnier, F | 2 |
| Lestavel, P | 2 |
| Adnet-Bonte, C | 1 |
| Reyford, H | 3 |
| Etchrivi, T | 1 |
| Tavernier, B | 2 |
| Krivosic-Horber, R | 6 |
| Deufel, T | 1 |
| Sudbrak, R | 1 |
| Feist, Y | 1 |
| Rübsam, B | 1 |
| Du Chesne, I | 1 |
| Schäfer, KL | 1 |
| Grimm, T | 1 |
| Hartung, EJ | 1 |
| Carr, AS | 1 |
| Lerman, J | 1 |
| Cunliffe, M | 1 |
| McLeod, ME | 1 |
| Britt, BA | 2 |
| Ducart, A | 1 |
| Renaud, B | 1 |
| Riou, B | 1 |
| O'Flynn, RP | 1 |
| Shutack, JG | 1 |
| Fletcher, JE | 11 |
| Kaufmann, MA | 1 |
| Drewe, J | 2 |
| Adnet, PJ | 9 |
| Krivosic-Horber, RM | 9 |
| Krivosic, I | 3 |
| Haudecoeur, G | 8 |
| Reyford, HG | 2 |
| Adamantidis, MM | 7 |
| Medahoui, H | 1 |
| Mortier, W | 1 |
| Breucking, E | 1 |
| Rempel, WE | 4 |
| Lu, M | 1 |
| el Kandelgy, S | 1 |
| Kennedy, CF | 1 |
| Irvin, LR | 1 |
| Mickelson, JR | 2 |
| Louis, CF | 3 |
| Calvo, PA | 1 |
| Payen, JF | 2 |
| Bosson, JL | 2 |
| Bourdon, L | 2 |
| Jacquot, C | 1 |
| Le Bas, JF | 1 |
| Stieglitz, P | 2 |
| Benabid, AL | 1 |
| Ellis, FR | 5 |
| Wedel, DJ | 4 |
| Gammel, SA | 1 |
| Milde, JH | 1 |
| Iaizzo, PA | 6 |
| Serfas, KD | 1 |
| Bose, D | 1 |
| Patel, L | 1 |
| Wrogemann, K | 1 |
| Phillips, MS | 1 |
| MacLennan, DH | 1 |
| Greenberg, CR | 1 |
| Wieland, SJ | 2 |
| Gong, QH | 2 |
| Gambelunghe, C | 1 |
| Mariucci, G | 1 |
| Bruschelli, G | 1 |
| Adami, M | 1 |
| de Rino, F | 1 |
| Ambrosini, MV | 1 |
| Sessler, DI | 2 |
| Neubert, E | 1 |
| Gürtler, H | 1 |
| Vallentin, G | 1 |
| Kozak-Ribbens, G | 1 |
| Confort-Gouny, S | 1 |
| Cozzone, PJ | 1 |
| Stewart, AD | 1 |
| Weglinski, MR | 1 |
| Engel, AG | 1 |
| Gilly, H | 2 |
| Musat, I | 1 |
| Bittner, RE | 2 |
| Steinbereithner, K | 3 |
| Kress, HG | 1 |
| Bachand, M | 1 |
| Vachon, N | 1 |
| Boisvert, M | 1 |
| Mayer, FM | 1 |
| Chartrand, D | 1 |
| Ben-Abraham, R | 1 |
| Haudcoeur, G | 1 |
| Perel, A | 1 |
| Mader, N | 1 |
| Glahn, K | 1 |
| Gardi, T | 1 |
| Fagerlund, T | 1 |
| Antognini, JF | 1 |
| Eisele, PH | 2 |
| Mezin, P | 1 |
| Brambilla, E | 1 |
| Ummenhofer, W | 1 |
| Roesslein, R | 1 |
| Sutter, PM | 1 |
| Moser, N | 1 |
| Kern, C | 1 |
| Winkler, G | 1 |
| Schulte am Esch, JS | 1 |
| Roughan, JV | 1 |
| Laming, PR | 1 |
| Goresky, GV | 1 |
| Cox, RG | 1 |
| Hawkes, CA | 1 |
| Etchrivi, TS | 1 |
| Diallo, A | 1 |
| Silva, HC | 1 |
| Bahia, VS | 1 |
| Oliveira, RA | 1 |
| Marchiori, PE | 1 |
| Scaff, M | 1 |
| Tsanaclis, AM | 1 |
| Agarwal, K | 1 |
| Matschke, J | 1 |
| Schulte Am Esch , J | 1 |
| Knowles, PF | 1 |
| Imbenotte, M | 3 |
| Cosgrove, SB | 1 |
| Martucci, RW | 2 |
| Peluso, A | 1 |
| Bianchini, A | 1 |
| Funk, B | 1 |
| McKenzie, AJ | 1 |
| Couchman, KG | 1 |
| Pollock, N | 1 |
| Kawana, Y | 1 |
| Iino, M | 1 |
| Oyamada, H | 1 |
| Endo, M | 1 |
| Zualkernan, K | 1 |
| Roghair, T | 1 |
| Reyford, GH | 1 |
| Cordonnier, C | 2 |
| Sánchez, V | 2 |
| Ryan, JF | 2 |
| Sreter, FA | 2 |
| Larach, MG | 2 |
| Landis, JR | 1 |
| Bunn, JS | 1 |
| Diaz, M | 1 |
| Martin, JJ | 1 |
| Van de Kelft, E | 1 |
| Bossaert, LL | 1 |
| Olthoff, D | 1 |
| Meinecke, CD | 1 |
| Preis, I | 1 |
| Engelhardt, W | 1 |
| Krauspe, R | 1 |
| Poels, PJ | 1 |
| Joosten, EM | 1 |
| Sengers, RC | 1 |
| Stadhouders, AM | 1 |
| Benders, AA | 1 |
| Slogoff, S | 1 |
| Keats, AS | 1 |
| Dear, WE | 1 |
| Abadia, A | 1 |
| Lawyer, JT | 1 |
| Moulds, JP | 1 |
| Williams, TM | 1 |
| Gallagher, WJ | 1 |
| Rum, U | 1 |
| Schmitz, W | 1 |
| Scholz, H | 1 |
| Seewald, MJ | 2 |
| Eichinger, HM | 2 |
| Theunynck, D | 4 |
| Guevart, E | 4 |
| Haguenoer, JM | 1 |
| Jaffe, RS | 1 |
| Elliott, TE | 1 |
| Cardinet, GH | 1 |
| Conti, PA | 2 |
| Olgin, J | 1 |
| Allen, G | 1 |
| Seestedt, R | 1 |
| Chance, B | 1 |
| Olsen, R | 1 |
| Chapman, DE | 1 |
| Berggren, M | 1 |
| Powis, G | 1 |
| Klip, A | 1 |
| Mills, GB | 1 |
| Elliott, ME | 1 |
| Kochs, E | 1 |
| Hoffman, WE | 1 |
| Allen, GC | 2 |
| Huggins, FJ | 1 |
| Reyfort, GH | 1 |
| Dupuis, BA | 3 |
| Foder, B | 1 |
| Scharff, O | 1 |
| Lopez, I | 1 |
| Mendoza, M | 1 |
| O'Brien, PJ | 3 |
| Kalow, BI | 2 |
| Ali, N | 1 |
| Lassaline, LA | 1 |
| Lumsden, JH | 2 |
| Cornet, C | 1 |
| Moeller, R | 1 |
| Laxenaire, MC | 1 |
| Adnet-Bonte, CA | 1 |
| Foster, PS | 1 |
| Hopkinson, KC | 1 |
| Denborough, MA | 1 |
| Hackl, W | 2 |
| Winkler, M | 1 |
| Mauritz, W | 2 |
| Burket, RC | 1 |
| Hodgin, JD | 1 |
| Ohnishi, ST | 1 |
| Katagi, H | 1 |
| Ohnishi, T | 1 |
| Brownell, AK | 1 |
| Brown, BD | 1 |
| Jacobs, RM | 1 |
| Beebe, JJ | 1 |
| Wackym, PA | 1 |
| Dubrow, TJ | 1 |
| Abdul-Rasool, IH | 1 |
| Lesavoy, MA | 1 |
| Adamantidis, M | 1 |
| Duthie, GG | 1 |
| Arthur, JR | 1 |
| Simpson, SP | 1 |
| Nicol, F | 1 |
| Klein, W | 1 |
| Sporn, P | 1 |
| Graf, M | 1 |
| Sluga, E | 1 |
| Gallant, EM | 2 |
| Bouvet, A | 1 |
| Yamashiro, S | 1 |
| Caroff, SN | 1 |
| Heiman-Patterson, TD | 1 |
| Mann, SC | 1 |
| Tolpin, EI | 1 |
| Michaux, K | 1 |
| Skovgaard, LT | 2 |
| Blomquist, S | 1 |
| Lunam, CA | 1 |
| Cousins, MJ | 1 |
| Hall, PM | 1 |
| Otsuka, S | 1 |
| Yamamoto, M | 1 |
| Kasuya, S | 1 |
| Ohtomo, H | 1 |
| Yamamoto, Y | 1 |
| Yoshida, TO | 1 |
| Akaza, T | 1 |
| Fletcher, TF | 1 |
| Goettl, VM | 1 |
| Krantz, P | 1 |
| Rooney, MT | 1 |
| Reik, TR | 1 |
| Thatte, HS | 1 |
| Addis, PB | 1 |
| Monti, M | 1 |
| Ilias, WK | 1 |
| Williams, CH | 1 |
| Fulfer, RT | 1 |
| Dozier, SE | 1 |
| Farrell, G | 1 |
| Prendergast, D | 1 |
| Murray, M | 1 |
| Fishbein, WN | 1 |
| Muldoon, SM | 1 |
| Deuster, PA | 1 |
| Armbrustmacher, VW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Freeman-Sheldon Syndrome Evaluation and Diagnosis in Clinical Settings (FSS-EDICT) I: a Case-Control, Cross-Sectional Study of Baseline and Stress Physiology Parameters[NCT01306994] | 0 participants (Actual) | Observational | 2014-03-31 | Withdrawn (stopped due to Lack of patient interest) | |||
| Implication of Patient in the Making Ready of Recommendations for the Antivitamin K's Gestion in Case of Thrombosis Embolic Venous's Illness. Randomised Study for Clinical Validation.[NCT00227097] | 300 participants | Observational | 2002-12-31 | Terminated | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for halothane and Diathesis
| Article | Year |
|---|---|
[Clinical features of malignant hyperthermia crisis].
Topics: Adolescent; Adult; Anesthesia, General; Arrhythmias, Cardiac; Carbon Dioxide; Child; Child, Preschoo | 1989 |
[Screening tests for malignant hyperthermia susceptibility].
Topics: Animals; Caffeine; Calcium; Cholinesterases; Contracture; Creatine Kinase; Cyclic AMP; Disease Susce | 1989 |
Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group.
Topics: Biopsy; Caffeine; Clinical Laboratory Techniques; Disease Susceptibility; Halothane; Humans; Maligna | 1989 |
Pathophysiology of malignant hyperthermia.
Topics: Animals; Calcium; Creatine Kinase; Dantrolene; Disease Susceptibility; Halothane; Humans; Lymphocyte | 1989 |
Diagnosis of susceptibility to malignant hyperthermia in man.
Topics: Caffeine; Chemistry, Clinical; Disease Susceptibility; Halothane; Hematologic Tests; Humans; In Vitr | 1988 |
4 trials available for halothane and Diathesis
| Article | Year |
|---|---|
Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility.
Topics: Biopsy; Caffeine; Cresols; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant | 2003 |
Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry.
Topics: Adolescent; Adult; Aged; Biopsy; Caffeine; Child; Contracture; Disease Susceptibility; Female; Halot | 1992 |
A blinded comparison of noninvasive, in vivo phosphorus nuclear magnetic resonance spectroscopy and the in vitro halothane/caffeine contracture test in the evaluation of malignant hyperthermia susceptibility.
Topics: Adolescent; Adult; Caffeine; Child; Child, Preschool; Disease Susceptibility; Female; Halothane; Hum | 1991 |
Cytosolic free calcium concentrations in lymphocytes from malignant hyperthermia susceptible patients.
Topics: Adult; Aged; Benzofurans; Calcium; Child; Cytosol; Disease Susceptibility; Female; Fura-2; Halothane | 1990 |
138 other studies available for halothane and Diathesis
| Article | Year |
|---|---|
Management of patients susceptible to malignant hyperthermia: A surgeon's perspective.
Topics: Caffeine; Child; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Retrospective St | 2022 |
Distinct pathophysiological characteristics in developing muscle from patients susceptible to malignant hyperthermia.
Topics: Caffeine; Calcium; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Muscle Contrac | 2023 |
Skeletal Muscle Metabolic Dysfunction in Patients With Malignant Hyperthermia Susceptibility.
Topics: Adult; Anesthetics; Anthropometry; Caffeine; Case-Control Studies; Disease Susceptibility; Exercise | 2017 |
Abnormal calcium signalling and the caffeine-halothane contracture test.
Topics: Adult; Anesthetics, Inhalation; Caffeine; Calcium; Cells, Cultured; Disease Susceptibility; Dose-Res | 2019 |
Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
Topics: Anesthetics, Inhalation; Biopsy; Disease Susceptibility; Dose-Response Relationship, Drug; Genetic P | 2013 |
Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia?
Topics: Adult; Anesthetics, Inhalation; Caffeine; Contracture; Disease Susceptibility; Female; Halothane; He | 2015 |
An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.
Topics: Adult; Biopsy; Caffeine; Case-Control Studies; Disease Susceptibility; Female; Halothane; Humans; La | 2008 |
Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study.
Topics: Anesthetics, Inhalation; Caffeine; Central Nervous System Stimulants; Disease Susceptibility; Dose-R | 2011 |
Halothane-induced calcium release in cultured human skeletal muscle cells from a family susceptible to malignant hyperthermia with an unidentified mutation in chromosome 19.
Topics: Calcium; Cells, Cultured; Chromosomes, Human, Pair 19; Disease Susceptibility; Halothane; Humans; Ma | 2002 |
Reproducibility of in vitro contracture test results in patients tested for malignant hyperthermia susceptibility.
Topics: Adult; Anesthetics, Inhalation; Biopsy; Caffeine; Disease Susceptibility; Female; Halothane; Humans; | 2002 |
"Noninvasive" testing for malignant hyperthermia susceptibility.
Topics: Caffeine; Calcium; Cresols; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Muscl | 2002 |
Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.
Topics: Adolescent; Adult; B-Lymphocytes; Caffeine; Calcium; Child; Cresols; Disease Susceptibility; Halotha | 2002 |
Malignant hyperthermia: update on susceptibility testing.
Topics: Algorithms; B-Lymphocytes; Biopsy; Caffeine; Disease Susceptibility; DNA Mutational Analysis; Haloth | 2005 |
The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs.
Topics: Anesthetics, Inhalation; Animals; Caffeine; Carbon Dioxide; Disease Susceptibility; Dose-Response Re | 2006 |
Effects of ryanodine on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
Topics: Animals; Caffeine; Disease Susceptibility; Halothane; Kinetics; Lactates; Malignant Hyperthermia; Mi | 2008 |
A minimally invasive metabolic test with intramuscular injection of halothane 5 and 6 vol% to detect probands at risk for malignant hyperthermia.
Topics: Adult; Anesthetics, Inhalation; Blood Pressure; Carbon Dioxide; Creatine Kinase; Disease Susceptibil | 2007 |
[Halothane test in the selection of stress-negative swine].
Topics: Animals; Crosses, Genetic; Disease Susceptibility; Drug Tolerance; Female; Halothane; Male; Meat; St | 1984 |
Investigation of malignant hyperthermia in Denmark and Sweden.
Topics: Adolescent; Adult; Aged; Biopsy; Caffeine; Child; Creatine Kinase; Disease Susceptibility; Female; G | 1984 |
A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.
Topics: Biopsy; Caffeine; Disease Susceptibility; Genetic Testing; Halothane; Humans; In Vitro Techniques; M | 1984 |
Halothane and halothane/succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars.
Topics: Animals; Disease Susceptibility; Drug Combinations; Halothane; Male; Malignant Hyperthermia; Ontario | 1983 |
Halothane stimulates the aggregation of platelets of both normal individuals and those susceptible to malignant hyperthermia.
Topics: Adenosine Diphosphate; Adolescent; Adult; Blood Platelets; Blood Proteins; Disease Susceptibility; F | 1983 |
Failure to induce malignant hyperthermia in myotonic goats.
Topics: Animals; Disease Susceptibility; Goats; Halothane; Malignant Hyperthermia; Myotonia Congenita; Succi | 1983 |
In vitro contracture tests for susceptibility to malignant hyperthermia.
Topics: Caffeine; Disease Susceptibility; Drug Interactions; Halothane; Humans; Malignant Hyperthermia; Musc | 1983 |
Spectrum of susceptibility to malignant hyperthermia--diagnostic dilemma.
Topics: Animals; Body Temperature; Caffeine; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; | 1983 |
Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase activities in pigs with different susceptibility to the malignant hyperthermia syndrome by halothane.
Topics: Animals; Blood Platelets; Disease Susceptibility; Dopamine beta-Hydroxylase; Female; Halothane; Male | 1981 |
Alterations of inositol polyphosphates in skeletal muscle during porcine malignant hyperthermia.
Topics: Anesthetics, Inhalation; Animals; Chromatography, High Pressure Liquid; Dantrolene; Disease Suscepti | 1995 |
C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.
Topics: Adolescent; Adult; Aged; Base Sequence; Caffeine; Calcium Channels; Child; Child, Preschool; Chromos | 1995 |
Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
Topics: Adult; Biopsy; Caffeine; Cocaine; Contracture; Disease Susceptibility; Female; Halothane; Humans; Ma | 1995 |
[Lack of sensitivity to per-anesthetic malignant hyperthermia in 32 patients who developed neuroleptic malignant syndrome].
Topics: Adolescent; Adult; Aged; Anesthesia, General; Caffeine; Contracture; Creatine Kinase; Dantrolene; Di | 1994 |
Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene.
Topics: Calcium Channels; Chromosomes, Human, Pair 19; Contracture; Disease Susceptibility; Female; Genetic | 1995 |
Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia Recovery Period; Anesthesia, Conduction; Anes | 1995 |
Malignant hyperthermia during sevoflurane administration.
Topics: Adult; Anesthetics; Caffeine; Disease Susceptibility; Ethers; Female; Halothane; Humans; Malignant H | 1995 |
Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
Topics: Adolescent; Biopsy; Caffeine; Child; Child, Preschool; Creatine Kinase; Disease Susceptibility; Fema | 1994 |
Genetic effects on the variability of the halothane and caffeine muscle contracture tests.
Topics: Adult; Biopsy; Caffeine; Child; Disease Susceptibility; Family; Fatal Outcome; Female; Halothane; Hu | 1994 |
Viability criterion of muscle bundles used in the in vitro contracture test in patients with neuromuscular diseases.
Topics: Caffeine; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Me | 1994 |
[Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
Topics: Adult; Caffeine; Child; Child, Preschool; Disease Susceptibility; Halothane; Humans; In Vitro Techni | 1993 |
Relative accuracy of the halothane challenge test and a molecular genetic test in detecting the gene for porcine stress syndrome.
Topics: Animals; Breeding; Calcium Channels; Disease Susceptibility; DNA; Female; Genotype; Halothane; Male; | 1993 |
Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation.
Topics: Animals; Base Sequence; Calcium; Calcium Channels; Disease Susceptibility; Genotype; Halothane; Hete | 1993 |
Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vivo with 31P-magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Aged; Biopsy; Caffeine; Disease Susceptibility; Female; Halothane; Humans; Magnet | 1993 |
Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
Topics: Caffeine; Disease Susceptibility; Dose-Response Relationship, Drug; Halothane; Humans; In Vitro Tech | 1993 |
Delayed onset of malignant hyperthermia induced by isoflurane and desflurane compared with halothane in susceptible swine.
Topics: Anesthetics; Animals; Desflurane; Disease Susceptibility; Halothane; Isoflurane; Malignant Hyperther | 1993 |
On the nature of the link between malignant hyperthermia and exertional heatstroke.
Topics: Animals; Body Temperature Regulation; Caffeine; Calcium Channels; Disease Models, Animal; Disease Su | 1995 |
Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
Topics: Anesthetics, Inhalation; Caffeine; Disease Susceptibility; Female; Halothane; Heterozygote; Humans; | 1996 |
Altered sodium current response to intracellular fatty acids in halothane-hypersensitive skeletal muscle.
Topics: Aging; Disease Susceptibility; Electric Conductivity; Fatty Acids; Halothane; Humans; Intracellular | 1996 |
Response variability to ischemic injury in the Mongolian gerbil: an electroencephalographic and behavioral study.
Topics: Anesthesia, Inhalation; Animals; Behavior, Animal; Brain Ischemia; Carotid Arteries; Coma; Constrict | 1996 |
Malignant hyperthermia.
Topics: Anesthesia, General; Caffeine; Counseling; Disease Susceptibility; Halothane; Humans; Malignant Hype | 1996 |
[Effect of acute stress on plasma levels of catecholamines and cortisol in addition to metabolites in stress-susceptible growing swine].
Topics: Animals; Blood Glucose; Disease Susceptibility; Epinephrine; Fatty Acids, Nonesterified; Halothane; | 1996 |
[Definition of a diagnostic score of malignant hyperthermia using P-31 magnetic resonance spectroscopy].
Topics: Caffeine; Contracture; Disease Susceptibility; Halothane; Humans; Magnetic Resonance Spectroscopy; M | 1996 |
An analysis of the predictive probability of the in vitro contracture test for determining susceptibility to malignant hyperthermia.
Topics: Adolescent; Adult; Aged; Biopsy; Caffeine; Child; Contracture; Disease Susceptibility; Halothane; Hu | 1997 |
Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels.
Topics: Adolescent; Adult; Anesthetics, Inhalation; Biopsy, Needle; Caffeine; Child; Child, Preschool; Clini | 1997 |
Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol.
Topics: Adolescent; Adult; Aged; Anesthetics, Inhalation; Caffeine; Cresols; Disease Susceptibility; Dose-Re | 1997 |
Clinical reassessment of malignant hyperthermia in Abitibi-Témiscamingue.
Topics: Adolescent; Adult; Caffeine; Child; Disease Susceptibility; Family Characteristics; Female; Halothan | 1997 |
[Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
Topics: Adolescent; Adult; Caffeine; Cresols; Disease Susceptibility; Halothane; Humans; In Vitro Techniques | 1997 |
Dystrophin deficient mdx muscle is not prone to MH susceptibility: an in vitro study.
Topics: Anesthetics, Inhalation; Animals; Caffeine; Disease Susceptibility; Dystrophin; Halothane; Male; Mal | 1997 |
4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.
Topics: Biopsy; Caffeine; Cresols; Disease Susceptibility; Dose-Response Relationship, Drug; Halothane; Huma | 1997 |
Evaluation for malignant hyperthermia susceptibility in black-tailed deer.
Topics: Anesthetics, Inhalation; Animals; Blood Gas Analysis; Cardiac Output; Deer; Disease Susceptibility; | 1996 |
Histological support for the difference between malignant hyperthermia susceptible (MHS), equivocal (MHE) and negative (MHN) muscle biopsies.
Topics: Adolescent; Adult; Aged; Anesthetics, Inhalation; Atrophy; Biopsy; Disease Susceptibility; Female; H | 1997 |
Muscle biopsy for malignant hyperthermia screening in children.
Topics: Adolescent; Anesthetics, Inhalation; Biopsy; Caffeine; Central Nervous System Stimulants; Child; Dis | 1997 |
Rhabdomyolysis following severe physical exercise in a patient with predisposition to malignant hyperthermia.
Topics: Adult; Anesthetics, Inhalation; Caffeine; Central Nervous System Stimulants; Disease Susceptibility; | 1998 |
Large slow potential shifts occur during halothane anaesthesia in gerbils.
Topics: Anesthesia; Animals; Behavior, Animal; Cerebral Cortex; Disease Susceptibility; Electrophysiology; G | 1998 |
Inhalation anesthetics and Duchenne's muscular dystrophy.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Contraindications; Disease Susceptibility; Haloth | 1999 |
Factitious halothane detection during trigger-free anesthesia in a malignant hyperthermia susceptible patient.
Topics: Adult; Anesthetics, Intravenous; Anesthetics, Local; Arthrodesis; Arthroscopy; Disease Susceptibilit | 1999 |
Effects of halothane on mechanical response of skeletal muscle from malignant hyperthermia susceptible patients.
Topics: Anesthetics, Inhalation; Biopsy; Caffeine; Disease Susceptibility; Halothane; Humans; In Vitro Techn | 1998 |
[Malignant hyperthermia susceptibility in 3 patients with malignant neuroleptic syndrome].
Topics: Adult; Caffeine; Contracture; Disease Susceptibility; Female; Halothane; Humans; Male; Malignant Hyp | 2000 |
Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis.
Topics: Adolescent; Adult; Anesthetics, Inhalation; Case-Control Studies; Child; Disease Susceptibility; Exe | 2001 |
Halothane effects on human malignant hyperthermia skeletal muscle single calcium-release channels in planar lipid bilayers.
Topics: Calcium Channels; Disease Susceptibility; Electric Stimulation; Halothane; Humans; Lipid Bilayers; M | 1992 |
Evaluation of spin resonance spectroscopy of red blood cell membranes to detect malignant hyperthermia susceptibility.
Topics: Disease Susceptibility; Electron Spin Resonance Spectroscopy; Erythrocyte Membrane; Halothane; Human | 1992 |
Effect of Bay K 8644 on the magnitude of isoflurane and halothane contracture of skeletal muscle from patients susceptible to malignant hyperthermia.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1992 |
Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures.
Topics: Anesthesia, Inhalation; Animals; Caffeine; Disease Susceptibility; Dog Diseases; Dogs; Genetic Predi | 1992 |
Malignant hyperthermia susceptibility in patients with Duchenne's muscular dystrophy.
Topics: Adolescent; Adult; Anesthesia, Inhalation; Anesthesia, Intravenous; Child; Child, Preschool; Disease | 1992 |
Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?
Topics: Caffeine; Culture Techniques; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Mus | 1992 |
Effect of halothane equilibration kinetics on in vitro muscle contractures for malignant hyperthermia screening.
Topics: Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contr | 1992 |
Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.
Topics: Adolescent; Adult; Anesthesia, Intravenous; Caffeine; Contracture; Disease Susceptibility; Halothane | 1992 |
[Effects of halothane, caffeine and ryanodine on the intracellular calcium store in blood mononuclear cells].
Topics: Animals; Caffeine; Calcium; Disease Susceptibility; Halothane; Humans; Leukocytes, Mononuclear; Mali | 1992 |
The effects of volatile anesthetics on calcium regulation by malignant hyperthermia-susceptible sarcoplasmic reticulum.
Topics: Animals; Calcium; Disease Susceptibility; Enflurane; Halothane; In Vitro Techniques; Isoflurane; Mal | 1992 |
Evidence for related myopathies in exertional heat stroke and malignant hyperthermia.
Topics: Adult; Biopsy; Caffeine; Disease Susceptibility; Family Health; Female; Halothane; Heat Exhaustion; | 1991 |
Use of the calcium agonist BAY K 8644 for in vitro diagnosis of susceptibility to malignant hyperthermia.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Effects of calcium-free solution, calcium antagonists, and the calcium agonist BAY K 8644 on mechanical responses of skeletal muscle from patients susceptible to malignant hyperthermia.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
EU 4093 decreases intracellular [Ca2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine.
Topics: Animals; Calcium; Disease Susceptibility; Dose-Response Relationship, Drug; Halothane; Imidazoles; M | 1992 |
In vitro contracture tests in patients with various neuromuscular diseases.
Topics: Adolescent; Adult; Aged; Caffeine; Child; Child, Preschool; Disease Susceptibility; Drug Hypersensit | 1992 |
[A new emphasis on the diagnosis of malignant hyperthermia using the in vitro contracture test?].
Topics: Adolescent; Adult; Caffeine; Child; Child, Preschool; Disease Susceptibility; Halothane; Humans; In | 1991 |
[Diagnosis of malignant hyperthermia. The platelet test versus the in vitro contracture test].
Topics: Blood Platelets; Caffeine; Child; Disease Susceptibility; Halothane; Humans; Male; Malignant Hyperth | 1991 |
In vitro contraction test for malignant hyperthermia in patients with unexplained recurrent rhabdomyolysis.
Topics: Adult; Caffeine; Calcium; Disease Susceptibility; Female; Halothane; Humans; Male; Malignant Hyperth | 1991 |
Steal-prone coronary anatomy and myocardial ischemia associated with four primary anesthetic agents in humans.
Topics: Anesthetics; Coronary Disease; Disease Susceptibility; Enflurane; Fentanyl; Halothane; Humans; Hypot | 1991 |
In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update.
Topics: Caffeine; Chromatography, Gas; Contracture; Diffusion Chambers, Culture; Disease Susceptibility; Ele | 1991 |
Effects of caffeine, halothane, succinylcholine, phenylephrine and isoproterenol on myocardial force of contraction of malignant hyperthermia susceptible swine.
Topics: Animals; Caffeine; Disease Susceptibility; Halothane; Isoproterenol; Malignant Hyperthermia; Myocard | 1991 |
Characterization of swine susceptible to malignant hyperthermia by in vivo, in vitro and post-mortem techniques.
Topics: Administration, Inhalation; Animals; Caffeine; Creatine Kinase; Disease Susceptibility; Genotype; Ha | 1991 |
[Malignant hyperthermia: halothane kinetics in a study model of muscular contraction. Head space determination and comparison with a mathematical model].
Topics: Chromatography; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hypertherm | 1991 |
Malignant hyperthermia: normal muscle calcium uptake and abnormal caffeine and halothane contractures.
Topics: Adult; Biopsy; Caffeine; Calcium; Disease Susceptibility; False Negative Reactions; Female; Halothan | 1991 |
Comparison of North American and European malignant hyperthermia group halothane contracture testing protocols in swine.
Topics: Animals; Disease Susceptibility; Europe; Halothane; Malignant Hyperthermia; Muscle Contraction; Nort | 1991 |
Enhanced mobilization of intracellular Ca2+ induced by halothane in hepatocytes isolated from swine susceptible to malignant hyperthermia.
Topics: Animals; Calcium; Disease Susceptibility; Halothane; In Vitro Techniques; Ions; Liver; Malignant Hyp | 1991 |
Halothane-dependent release of intracellular Ca2+ in blood cells in malignant hyperthermia.
Topics: Animals; Caffeine; Calcium; Cytosol; Disease Susceptibility; Egtazic Acid; Halothane; Humans; Malign | 1990 |
Alterations in brain electrical activity may indicate the onset of malignant hyperthermia in swine.
Topics: Anesthesia, Inhalation; Animals; Brain; Disease Susceptibility; Electroencephalography; Halothane; M | 1990 |
Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?
Topics: Biopsy; Caffeine; Calcium; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant | 1990 |
Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group.
Topics: Animals; Caffeine; Disease Susceptibility; Halothane; In Vitro Techniques; Malignant Hyperthermia; M | 1990 |
Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia.
Topics: Caffeine; Disease Susceptibility; False Negative Reactions; Halothane; Humans; In Vitro Techniques; | 1990 |
Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility.
Topics: Anesthesia, General; Caffeine; Contracture; Disease Susceptibility; Halothane; Humans; Malignant Hyp | 1990 |
The effects of extracellular magnesium on myoplasmic [Ca2+] in malignant hyperthermia susceptible swine.
Topics: Animals; Calcium; Dantrolene; Disease Susceptibility; Extracellular Space; Halothane; Magnesium Sulf | 1990 |
Current diagnostic methods of malignant hyperthermia: an evaluation.
Topics: Caffeine; Chromosomes, Human, Pair 19; Disease Susceptibility; Halothane; Humans; Magnetic Resonance | 1990 |
Diltiazem and nifedipine reduce the in vitro contracture response to halothane in malignant hyperthermia-susceptible muscle.
Topics: Depression, Chemical; Diltiazem; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Mal | 1990 |
Compensatory increase in calcium extrusion activity of untreated lymphocytes from swine susceptible to malignant hyperthermia.
Topics: Animals; Caffeine; Calcium; Disease Susceptibility; Halothane; Lymphocytes; Malignant Hyperthermia; | 1990 |
Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses.
Topics: Animals; Body Temperature; Calcium; Disease Susceptibility; Halothane; In Vitro Techniques; Malignan | 1990 |
Malignant hyperthermia: slow sodium current in cultured human muscle cells.
Topics: Caffeine; Cells, Cultured; Disease Susceptibility; Electric Conductivity; Halothane; Humans; Maligna | 1989 |
The association between the neuroleptic malignant syndrome and malignant hyperthermia.
Topics: Adult; Caffeine; Chlorpromazine; Contracture; Disease Susceptibility; Female; Halothane; Humans; Mal | 1989 |
Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle.
Topics: Caffeine; Dantrolene; Diltiazem; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Mal | 1989 |
[The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
Topics: Caffeine; Disease Susceptibility; Halothane; In Vitro Techniques; Ketamine; Malignant Hyperthermia; | 1989 |
Fluoxetine treatment of a depressed patient susceptible to malignant hyperthermia.
Topics: Adolescent; Caffeine; Depressive Disorder; Disease Susceptibility; Female; Fluoxetine; Halothane; Hu | 1989 |
Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle.
Topics: Anesthesia; Caffeine; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Interactions; H | 1989 |
Detection of malignant hyperthermia susceptibility using a spin label technique on red blood cells.
Topics: Cyclic N-Oxides; Disease Susceptibility; Electron Spin Resonance Spectroscopy; Erythrocytes; Halotha | 1988 |
Porcine malignant hyperthermia susceptibility: halothane-induced increase in cytoplasmic free calcium in lymphocytes.
Topics: Animals; Calcium; Cytosol; Disease Susceptibility; Halothane; Lymphocytes; Malignant Hyperthermia; S | 1989 |
Preparation of anesthesia machines for patients susceptible to malignant hyperthermia.
Topics: Anesthesia, Inhalation; Anesthesiology; Chromatography, Gas; Disease Susceptibility; Equipment Conta | 1988 |
Malignant hyperthermia in plastic surgery.
Topics: Adult; Caffeine; Child; Child, Preschool; Dermoid Cyst; Disease Susceptibility; Facial Neoplasms; Fe | 1988 |
[Tests of contracture and sensitivity to malignant hyperthermia in 27 patients].
Topics: Adolescent; Adult; Anesthesia, General; Biopsy; Caffeine; Child; Child, Preschool; Contracture; Crea | 1988 |
Plasma pyruvate kinase activity vs creatine kinase activity as an indicator of the porcine stress syndrome.
Topics: Animals; Clinical Enzyme Tests; Creatine Kinase; Disease Susceptibility; Female; Halothane; Male; Ma | 1988 |
Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs.
Topics: Animals; Benzofurans; Caffeine; Calcium; Disease Susceptibility; Fura-2; Halothane; Malignant Hypert | 1988 |
[Malignant hyperthermia in Austria. II. A comparison of the results of diagnostic test procedures].
Topics: Adult; Caffeine; Creatine Kinase; Disease Susceptibility; Electromyography; Female; Halothane; Human | 1988 |
Neuroleptic malignant syndrome and malignant hyperthermia. In vitro comparison with halothane and caffeine contracture tests.
Topics: Adult; Aged; Caffeine; Disease Susceptibility; Female; Halothane; Humans; In Vitro Techniques; Male; | 1987 |
Porcine malignant hyperthermia: false negatives in the halothane test.
Topics: Animals; Disease Susceptibility; False Negative Reactions; Genotype; Halothane; Malignant Hypertherm | 1987 |
Platelet alterations in porcine stress syndrome.
Topics: Animals; Blood Platelets; Disease Susceptibility; Halothane; Male; Microscopy, Electron; Stress, Phy | 1987 |
Malignant hyperthermia susceptibility in neuroleptic malignant syndrome.
Topics: Adult; Disease Susceptibility; Female; Fluphenazine; Halothane; Humans; Male; Malignant Hyperthermia | 1987 |
Effects of anaesthetic agents on erythrocyte fragility: comparison of normal and malignant hyperthermia susceptible patients.
Topics: Disease Susceptibility; Ethanol; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Osm | 1987 |
In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethonium.
Topics: Caffeine; Disease Susceptibility; Evaluation Studies as Topic; Halothane; Humans; In Vitro Technique | 1987 |
In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests.
Topics: Caffeine; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Mu | 1987 |
Static v. dynamic tests in the in vitro diagnosis of malignant hyperthermia susceptibility.
Topics: Caffeine; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Male; Malignant Hypertherm | 1986 |
Genetic predisposition to liver damage after halothane anesthesia in guinea pigs.
Topics: Alanine Transaminase; Animals; Breeding; Chemical and Drug Induced Liver Injury; Disease Susceptibil | 1986 |
[Examination of the family of a patient susceptible to anesthetic malignant hyperthermia].
Topics: Adolescent; Adult; Biopsy; Disease Susceptibility; Female; Halothane; Humans; Male; Malignant Hypert | 1986 |
In vitro muscle contractures induced by halothane and suxamethonium. II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients.
Topics: Disease Susceptibility; Fatty Acids, Nonesterified; Halothane; Humans; In Vitro Techniques; Indometh | 1986 |
HLA antigens in patients with unexplained hepatitis following halothane anesthesia.
Topics: Adolescent; Adult; Aged; Anesthetics; Chemical and Drug Induced Liver Injury; Child; Cholestasis, In | 1985 |
Malignant hyperthermia.
Topics: Adult; Anesthesia; Animals; Caffeine; Child; Creatine Kinase; Disease Susceptibility; Halothane; Hum | 1985 |
Porcine malignant hyperthermia: cell injury enhances halothane sensitivity of biopsies.
Topics: Animals; Caffeine; Disease Susceptibility; Halothane; Hybridization, Genetic; In Vitro Techniques; M | 1986 |
Malignant hyperpyrexia and sudden death.
Topics: Adolescent; Adult; Caffeine; Death, Sudden; Disease Susceptibility; Halothane; Humans; Male; Maligna | 1985 |
In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity.
Topics: Caffeine; Disease Susceptibility; Drug Interactions; Halothane; Humans; In Vitro Techniques; Maligna | 1985 |
Porcine malignant hyperthermia susceptibility: erythrocytic osmotic fragility.
Topics: Animals; Creatine Kinase; Crosses, Genetic; Disease Susceptibility; Erythrocytes; Glutathione Peroxi | 1985 |
Laboratory diagnosis of malignant hyperpyrexia susceptibility (MHS). European MH Group.
Topics: Caffeine; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia | 1985 |
Microcalorimetric studies in malignant hyperpyrexia susceptible individuals.
Topics: Blood Platelets; Body Temperature Regulation; Caffeine; Calorimetry; Disease Susceptibility; Halotha | 1985 |
Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.
Topics: Animals; Benzazepines; Caffeine; Depression, Chemical; Diltiazem; Disease Susceptibility; Halothane; | 1985 |
Halothane hepatitis. Detection of a constitutional susceptibility factor.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Disease Susceptibility; Drug Evaluation, Precli | 1985 |
Myoadenylate deaminase deficiency and malignant hyperthermia susceptibility: is there a relationship?
Topics: Adenylate Kinase; Adult; AMP Deaminase; Caffeine; Creatine Kinase; Disease Susceptibility; Female; H | 1985 |